Literature DB >> 9132281

Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections.

M Wallace1, A M Scharko, C D Pauza, P Fisch, K Imaoka, S Kawabata, K Fujihashi, H Kiyono, Y Tanaka, B R Bloom, M Malkovsky.   

Abstract

BACKGROUND: Antiviral cellular immune responses may influence immunological homeostasis in HIV-infected persons. Recent data indicate that V gamma 9/V delta 2 T lymphocytes display potent cytotoxic activities against human cells infected with certain viruses including HIV. Understanding the role of gamma delta T cells in the course of HIV infection may be helpful for designing novel treatment strategies for HIV-associated disorders.
MATERIALS AND METHODS: The constitutive recognition of Daudi cells and monoethyl pyrophosphate (Etpp) by peripheral blood V gamma 9/V delta 2 T cells was assessed using a proliferation assay. The cytotoxicity of Daudi-stimulated lymphocyte populations was measured by chromium release assays. The HIV infectivity for gamma delta T cell clones was determined by measuring the levels of HIV p24 in cell supernatants. The effect of in vitro HIV-infection on cytokine mRNA production by gamma delta T cell clones was assessed by PCR.
RESULTS: The constitutive proliferative responses of peripheral blood V gamma 9/V delta 2 T cells and the lytic functions of Daudi-expanded lymphoid cells from HIV+ persons were substantially diminished in comparison with those of HIV-seronegative persons. These alterations were present in asymptomatic HIV+ persons prior to substantial alpha beta CD4+ T cell loss. Productive HIV infection of gamma delta T cells in vitro had no measurable effect either on their proliferative response to Daudi stimuli or on the expression of cytokine mRNAs for IFN-gamma, IL-2, IL-4, IL-5, IL-6, IL-10, and IL-13.
CONCLUSIONS: The constitutive responsiveness of V gamma 9/V delta 2 T lymphocytes to Daudi and Etpp is severely altered in HIV+ persons. HIV infection of gamma delta T cells in vitro does not substantially change their cytokine expression or antigenic response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9132281      PMCID: PMC2230098     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  44 in total

1.  Structural and serological heterogeneity of gamma/delta T cell antigen receptor expression in thymus and peripheral blood.

Authors:  L L Lanier; J Ruitenberg; R L Bolhuis; J Borst; J H Phillips; R Testi
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

2.  Gamma delta T lymphocyte responses to HIV.

Authors:  M Wallace; S R Bartz; W L Chang; D A Mackenzie; C D Pauza; M Malkovsky
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

3.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

4.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

Authors:  Y Tanaka; C T Morita; Y Tanaka; E Nieves; M B Brenner; B R Bloom
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

5.  Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells.

Authors:  C T Morita; E M Beckman; J F Bukowski; Y Tanaka; H Band; B R Bloom; D E Golan; M B Brenner
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

6.  Gamma delta T cells in rhesus monkeys and their response to simian immunodeficiency virus (SIV) infection.

Authors:  Y H Gan; C D Pauza; M Malkovsky
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

7.  Mycobacteria-reactive gamma delta T cells in HIV-infected individuals: lack of V gamma 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells.

Authors:  D Wesch; D Kabelitz; K Friese; K Pechhold
Journal:  Eur J Immunol       Date:  1996-03       Impact factor: 5.532

8.  Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues.

Authors:  K Fujihashi; M Yamamoto; T Hiroi; T V Bamberg; J R McGhee; H Kiyono
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

9.  Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire.

Authors:  C M Parker; V Groh; H Band; S A Porcelli; C Morita; M Fabbi; D Glass; J L Strominger; M B Brenner
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis.

Authors:  P Fisch; M Malkovsky; E Braakman; E Sturm; R L Bolhuis; A Prieve; J A Sosman; V A Lam; P M Sondel
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  37 in total

Review 1.  Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors.

Authors:  M L Gougeon; F Poccia; S Boullier
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

Review 3.  Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.

Authors:  Richard D Lopez
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.

Authors:  Alanna S Murday; Suchita Chaudhry; C David Pauza
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

Review 5.  HIV infection: focus on the innate immune cells.

Authors:  Milena S Espíndola; Luana S Soares; Leonardo J Galvão-Lima; Fabiana A Zambuzi; Maira C Cacemiro; Verônica S Brauer; Fabiani G Frantz
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

6.  HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS.

Authors:  Haishan Li; C David Pauza
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

7.  In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.

Authors:  F Poccia; M Malkovsky; A Pollak; V Colizzi; G Sireci; A Salerno; F Dieli
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

8.  The potential role of CD16+ Vγ2Vδ2 T cell-mediated antibody-dependent cell-mediated cytotoxicity in control of HIV type 1 disease.

Authors:  Xuan He; Hua Liang; Kunxue Hong; Haishan Li; Hong Peng; Yangyang Zhao; Manxue Jia; Yuhua Ruan; Yiming Shao
Journal:  AIDS Res Hum Retroviruses       Date:  2013-09-13       Impact factor: 2.205

9.  Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.

Authors:  David J Riedel; Mohammad M Sajadi; Cheryl L Armstrong; Jean-Saville Cummings; Cristiana Cairo; Robert R Redfield; C David Pauza
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

Review 10.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.